These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6936969

  • 1. Antileukemic activity of 4-demethoxydaunorubicin in mice.
    Casazza AM, Pratesi G, Giuliani F, Di Marco A.
    Tumori; 1980 Oct 31; 66(5):549-64. PubMed ID: 6936969
    [Abstract] [Full Text] [Related]

  • 2. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM.
    Cancer Res; 1983 Jun 31; 43(6):2880-3. PubMed ID: 6573953
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S.
    J Antibiot (Tokyo); 1988 Feb 31; 41(2):193-8. PubMed ID: 3356607
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
    Arcamone F, Bernardi L, Giardino P, Patelli B, Marco A, Casazza AM, Pratesi G, Reggiani P.
    Cancer Treat Rep; 1976 Jul 31; 60(7):829-34. PubMed ID: 1009518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 31; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid.
    Zunino F, Giuliani F, Savi G, Dasdia T, Gambetta R.
    Int J Cancer; 1982 Oct 15; 30(4):465-70. PubMed ID: 7141741
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
    Adams N, Blake C, Broadhurst MJ, Bushnell DJ, Hassall CH, Hartmann HR, Keech E, Stratton AR, Thomas GJ.
    J Med Chem; 1990 Sep 15; 33(9):2375-9. PubMed ID: 2391681
    [Abstract] [Full Text] [Related]

  • 13. Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia.
    Tsuruo T, Oh-Hara T, Sudo Y, Naito M.
    Anticancer Res; 1993 Sep 15; 13(2):357-61. PubMed ID: 8517647
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.
    Formelli F, Casazza AM, Di Marco A, Mariani A, Pollini C.
    Cancer Chemother Pharmacol; 1979 Sep 15; 3(4):261-9. PubMed ID: 294954
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
    Kuśnierczyk H, Rak J, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1986 Sep 15; 34(3):259-62. PubMed ID: 3592929
    [Abstract] [Full Text] [Related]

  • 17. Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    Szmigielska-Kaplon A, Ciesielska E, Szmigiero L, Robak T.
    Eur J Haematol; 2002 Jun 15; 68(6):370-5. PubMed ID: 12225395
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
    Kimura Y, Matsumoto T, Suzuki M, Terashima S.
    J Antibiot (Tokyo); 1985 Sep 15; 38(9):1277-9. PubMed ID: 4066509
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
    Thang TT, Imbach JL, Fizames C, Lavelle F, Ponsinet G, Olesker A, Lukacs G.
    Carbohydr Res; 1985 Jan 15; 135(2):241-7. PubMed ID: 3986844
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
    Goldin A, Venditti JM, Geran R.
    Invest New Drugs; 1985 Jan 15; 3(1):3-21. PubMed ID: 3886588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.